Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp).

被引：29
|
作者：
Le, Xiuning
Paz-Ares, Luis G.
Van Meerbeeck, Jan
Viteri, Santiago
Galvez, Carlos Cabrera
Baz, David Vicente
Kim, Young-Chul
Kang, Jin-Hyoung
Schumacher, Karl-Maria
Karachaliou, Niki
Adrian, Svenja
Bruns, Rolf
Paik, Paul K.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Hosp Univ 12 Octubre, Madrid, Spain
[3] Antwerp Univ Hosp UZA, Edegem, Belgium
[4] Dexeus Univ Hosp, Dr Rosell Oncol Inst, Quiron Salud Grp, Barcelona, Spain
[5] Hosp Univ Sagrat Cor, Barcelona, Spain
[6] Hosp Univ Virgen Macarena, Serv Oncol, Seville, Spain
[7] Chonnam Natl Univ, Hwasun Hosp 13868, Hwasun Gun, South Korea
[8] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
[9] Merck KGaA, Global Clin Dev, Darmstadt, Germany
[10] Merck KGaA, Darmstadt, Germany
[11] Merck KGaA, Dept Biostat, Darmstadt, Germany
[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9021
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Tepotinib in Patients with Advanced NSCLC with MET Amplification (METamp)
    Le, X.
    O'Hara, R.
    Paz-Ares, L.
    Van Meerbeeck, J. P.
    Ramirez, S. Viteri
    Galvez, C. Cabrera
    Baz, D. Vincente
    Kim, Y. C.
    Kang, J. H.
    Schumacher, K. M.
    Karachaliou, N.
    Adrian, S.
    Bruns, R.
    Paik, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : E6 - E7
  • [2] Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp); A phase II trial in progress
    Paik, P.
    Sakai, H.
    Bruns, R.
    Scheele, J.
    Straub, J.
    Felip, E.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [3] Biomarker testing and treatment patterns in US patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) harboring MET amplification
    Ryder, Alex
    Oksen, Dina
    Boutmy, Emmanuelle
    Wang, Yuexi
    Nisbett, Alnecia R.
    Stroh, Christopher
    Johne, Andreas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Treatment outcomes in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) harboring MET amplification as a secondary oncogenic driver
    Ryder, Alex
    Oksen, Dina
    Boutmy, Emmanuelle
    Ellers-Lenz, Barbara
    Stroh, Christopher
    Karachaliou, Niki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Health utility with tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC)
    Reinmuth, N.
    Popat, S.
    Paz-Ares, L.
    Knowles, E.
    Hatswell, A.
    McLean, T.
    Adrian, S.
    Gaumond, B.
    Vioix, H.
    Paik, P. K.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S985 - S986
  • [6] ANALYSIS OF C-MET GENE AMPLIFICATION IN JAPANESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Sone, Takashi
    Matsui, Tomohiro
    Kurokawa, Kouji
    Sakai, Asao
    Kasahara, Kazuo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S462 - S462
  • [7] Analysis of c-Met gene amplification in Japanese patients with advanced non-small cell lung cancer (NSCLC)
    Sone, T.
    Kasahara, K.
    Sakai, A.
    Ikeda, H.
    Kurokawa, K.
    Fujimura, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Trends in demographics and survival for patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Kubota, K.
    Masuhara, H.
    Hosoya, K.
    Yoh, K.
    Niho, S.
    Goto, K.
    Ohmatsu, H.
    Nishiwaki, Y.
    Saijo, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 392S - 392S
  • [9] MET exon 14 skipping mutations in advanced non-small cell lung cancer (NSCLC) are not associated with MET amplification and overexpression
    Gimenez-Capitan, Ana
    Teixido, Cristina
    Aguado, Cristina
    Rodriguez, Sonia
    Bertran-Alamillo, Jordi
    Castellvi, Josep
    Yeste, Zaira
    Perez, Ana
    Rosell, Rafael
    Molina-Vila, Miguel Angel
    [J]. CANCER RESEARCH, 2017, 77
  • [10] Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, Hye Ryun
    Gridelli, Cesare
    Kapur, Dinesh
    Tufman, Amanda
    Felip, Enriqueta
    Velcheti, Vamsidhar
    Kim, Yu Jung
    Goetze, Thorsten
    Lopez, Pilar Garrido
    Corre, Romain
    Penkov, Konstantin
    Anjum, Rana
    Di Pace, Brian
    Liu, Wenlei
    Borgovan, Theo
    Ledger, Danielle
    Carver, Jennifer
    Waszak, Angela
    Dhar, Arindam
    Novello, Silvia
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 163 - 163
12345